Woodline Partners LP Surmodics Inc Transaction History
Woodline Partners LP
- $17.6 Billion
- Q2 2025
A detailed history of Woodline Partners LP transactions in Surmodics Inc stock. As of the latest transaction made, Woodline Partners LP holds 144,977 shares of SRDX stock, worth $4.69 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
144,977Holding current value
$4.69 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding SRDX
# of Institutions
143Shares Held
12.4MCall Options Held
103KPut Options Held
212K-
Black Rock Inc. New York, NY1.17MShares$37.9 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY850KShares$27.5 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA810KShares$26.2 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT789KShares$25.5 Million1.82% of portfolio
-
Morgan Stanley New York, NY656KShares$21.2 Million0.0% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $453M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...